HAEMOPHILIA A
Clinical trials for HAEMOPHILIA A explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study tracks Esperoct's Long-Term impact on bleeding disorder
Disease control ENROLLING_BY_INVITATIONThis study follows about 60 males with hemophilia A who are already using Esperoct to prevent bleeding. Researchers will monitor side effects and how well the medicine works over 5 to 7 years. Participants continue their normal treatment and clinic visits, with no extra procedure…
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 12:10 UTC
-
New drug Mim8 aims to prevent bleeds in hemophilia a patients
Disease control OngoingThis study tests a new medicine called Mim8 in people with hemophilia A, a condition where blood does not clot properly. Mim8 helps replace a missing clotting factor to prevent bleeding episodes. About 451 participants will receive injections over up to 5.5 years, and researchers…
Matched conditions: HAEMOPHILIA A
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated May 26, 2026 12:08 UTC
-
Researchers track side effects of Blood-Clotting drug in haemophilia patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers safety information from a European registry about the drug turoctocog alfa pegol, used to treat haemophilia A. Researchers will count and analyze side effects reported by patients already in the registry. No extra visits or tests are required from participants.
Matched conditions: HAEMOPHILIA A
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated May 18, 2026 11:59 UTC